CoreCap Advisors’s BlackRock Health Sciences Trust II BMEZ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$15.3K Hold
1,000
﹤0.01% 1907
2026
Q1
$14.4K Hold
1,000
﹤0.01% 1802
2025
Q4
$15.1K Hold
1,000
﹤0.01% 1798
2025
Q3
$14.4K Sell
1,000
-9,000
-90% -$128K ﹤0.01% 1788
2025
Q2
$143K Sell
10,000
-5,700
-36% -$81.5K 0.01% 861
2025
Q1
$234K Buy
15,700
+9,500
+153% +$149K 0.01% 638
2024
Q4
$89.3K Sell
6,200
-9,500
-61% -$147K ﹤0.01% 971
2024
Q3
$249K Buy
+15,700
New +$248K 0.01% 618
2024
Q2
Sell
-2,700
Closed -$44.3K 1722
2024
Q1
$44.3K Buy
+2,700
New +$42.6K ﹤0.01% 1161

Other funds holding BMEZ

CoreCap Advisors's BMEZ Position: Q2 2026 in Review

CoreCap Advisors held its BlackRock Health Sciences Trust II (BMEZ) position steady in Q2 2026 at 1,000 shares worth $15.3K. The position accounts for ﹤0.01% of the portfolio, ranked #1907.

CoreCap Advisors first reported a position in BMEZ in Q1 2024 and has held it in 9 quarters since. The position peaked at $249K in Q3 2024. 88 funds tracked by Wall St. Rank hold BMEZ as of Q2 2026.

  • CoreCap Advisors held 1,000 shares of BlackRock Health Sciences Trust II worth $15.3K as of Q2 2026.
  • CoreCap Advisors left its BlackRock Health Sciences Trust II share count unchanged in Q2 2026.
  • BlackRock Health Sciences Trust II made up ﹤0.01% of CoreCap Advisors's portfolio in Q2 2026, its #1907 holding.
  • CoreCap Advisors first reported a position in BlackRock Health Sciences Trust II in Q1 2024 and has held it in 9 quarters since.
  • CoreCap Advisors's BlackRock Health Sciences Trust II position peaked at $249K in Q3 2024.
  • 88 funds tracked by Wall St. Rank held BlackRock Health Sciences Trust II as of Q2 2026.

Based on CoreCap Advisors's 13F filing for Q2 2026, filed 6 Jul 2026.